- Review the diagnosis, evaluation, and treatment of osteoporosis.
- Evaluate the evidence for use of osteoclast inhibitors in early breast cancer and review current guidelines.
- Understand the risks of bone loss and vertebral fractures after denosumab discontinuation and discuss sequential use of bisphosphonates to prevent these complications.
Monday, November 11, 2019 - 12:00pm to 1:00pm
900 East 57th StreetKCBD Auditorium 1103
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Laura T. Dickens, MD